Embryonic Stem (ES) Cell FBS Qualified

Speakers
  • Scientist II, Thermo Fisher Scientific
    Biography
      Carl Dargitz received his Master's degree from California Polytechnic State University, San Luis Obispo in Biomedical Engineering with a specialization in stem cell research in 2013. During that time he worked as an intern at The Salk Institute in Dr. Inder Verma's lab under the tutelage of Dr. Amy Firth. His Master's thesis project involved differentiating iPSCs into lung airway epithelium to study Cystic Fibrosis. From 2013-2016 he worked at the stem cell core facility at The Salk Institute managing the core's reprogramming services. In August 2016 he joined the stem cell R&D team at Thermo Fisher Scientific as a Scientist II developing reprogramming, PSC characterization, and immunoncology characterization products.

    Abstract:

    Thermo Fisher Scientific has developed an advanced assay to qualify FBS for use with ESCs.  This assay is designed to sustain undifferentiated ES cells while maintaining karyotype integrity, LIF responsiveness and pluripotency markers.  ES Cell FBS Qualified, has proven applications in reprogramming, pluripotency marker maintenance, and PSC morphology maintenance.  When compared to competing products, it shows superior performance with regard to morphology and maintenance of pluripotency. The stringency of this assay provides researchers with the highest quality FBS for use in ES cell culture.


    Show Resources
    You May Also Like
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources